nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—chronic obstructive pulmonary disease—asthma	0.168	1	CtDrD
Formoterol—Arformoterol—asthma	0.101	0.545	CrCtD
Formoterol—Isoprenaline—asthma	0.0846	0.455	CrCtD
Formoterol—Adrenergic beta2-Agonists—Orciprenaline—asthma	0.0539	0.181	CiPCiCtD
Formoterol—Adrenergic beta2-Agonists—Pirbuterol—asthma	0.0539	0.181	CiPCiCtD
Formoterol—Adrenergic beta2-Agonists—Salmeterol—asthma	0.0539	0.181	CiPCiCtD
Formoterol—Adrenergic beta2-Agonists—Indacaterol—asthma	0.0539	0.181	CiPCiCtD
Formoterol—ADRB2—asthma	0.0508	1	CbGaD
Formoterol—Adrenergic beta2-Agonists—Salbutamol—asthma	0.0408	0.137	CiPCiCtD
Formoterol—Adrenergic beta2-Agonists—Arformoterol—asthma	0.0408	0.137	CiPCiCtD
Formoterol—ADRB2—Orciprenaline—asthma	0.0113	0.0889	CbGbCtD
Formoterol—Arbutamine—Salmeterol—asthma	0.0105	0.0845	CrCrCtD
Formoterol—Fenoterol—Orciprenaline—asthma	0.0105	0.0845	CrCrCtD
Formoterol—Dobutamine—Arformoterol—asthma	0.0103	0.0826	CrCrCtD
Formoterol—Arformoterol—Isoprenaline—asthma	0.00957	0.0767	CrCrCtD
Formoterol—Fenoterol—Terbutaline—asthma	0.00914	0.0732	CrCrCtD
Formoterol—ADRB2—Pirbuterol—asthma	0.00859	0.0674	CbGbCtD
Formoterol—ADRB2—Terbutaline—asthma	0.00859	0.0674	CbGbCtD
Formoterol—ADRB2—Isoetarine—asthma	0.00859	0.0674	CbGbCtD
Formoterol—ADRB1—Pirbuterol—asthma	0.00846	0.0664	CbGbCtD
Formoterol—ADRB1—Isoetarine—asthma	0.00846	0.0664	CbGbCtD
Formoterol—Fenoterol—Arformoterol—asthma	0.00799	0.064	CrCrCtD
Formoterol—Ritodrine—Arformoterol—asthma	0.00799	0.064	CrCrCtD
Formoterol—Arbutamine—Arformoterol—asthma	0.00699	0.056	CrCrCtD
Formoterol—Labetalol—Salmeterol—asthma	0.00668	0.0536	CrCrCtD
Formoterol—Fenoterol—Isoprenaline—asthma	0.00666	0.0534	CrCrCtD
Formoterol—Isoprenaline—Orciprenaline—asthma	0.00605	0.0485	CrCrCtD
Formoterol—ADRB2—Indacaterol—asthma	0.00595	0.0467	CbGbCtD
Formoterol—ADRB1—Indacaterol—asthma	0.00586	0.046	CbGbCtD
Formoterol—Arbutamine—Isoprenaline—asthma	0.00583	0.0467	CrCrCtD
Formoterol—ADRB2—Salmeterol—asthma	0.00553	0.0434	CbGbCtD
Formoterol—ADRB2—Salbutamol—asthma	0.00553	0.0434	CbGbCtD
Formoterol—ADRB1—Salbutamol—asthma	0.00545	0.0428	CbGbCtD
Formoterol—Isoprenaline—Terbutaline—asthma	0.00525	0.0421	CrCrCtD
Formoterol—Isoprenaline—Isoetarine—asthma	0.00505	0.0405	CrCrCtD
Formoterol—ADRB2—Isoprenaline—asthma	0.00471	0.0369	CbGbCtD
Formoterol—ADRB1—Isoprenaline—asthma	0.00463	0.0364	CbGbCtD
Formoterol—Isoprenaline—Arformoterol—asthma	0.00459	0.0368	CrCrCtD
Formoterol—Labetalol—Arformoterol—asthma	0.00443	0.0355	CrCrCtD
Formoterol—ADRB2—Arformoterol—asthma	0.00419	0.0329	CbGbCtD
Formoterol—ADRB1—Arformoterol—asthma	0.00413	0.0324	CbGbCtD
Formoterol—Labetalol—Isoprenaline—asthma	0.00369	0.0296	CrCrCtD
Formoterol—Isoprenaline—Salbutamol—asthma	0.00348	0.0279	CrCrCtD
Formoterol—CYP2A6—Arformoterol—asthma	0.00334	0.0262	CbGbCtD
Formoterol—CYP2A6—Montelukast—asthma	0.00253	0.0199	CbGbCtD
Formoterol—CYP2D6—Ciclesonide—asthma	0.00149	0.0117	CbGbCtD
Formoterol—CYP2A6—Prednisolone—asthma	0.00149	0.0117	CbGbCtD
Formoterol—CYP2C19—Zafirlukast—asthma	0.00143	0.0112	CbGbCtD
Formoterol—CYP2C19—Arformoterol—asthma	0.00138	0.0109	CbGbCtD
Formoterol—CYP2C9—Zileuton—asthma	0.00135	0.0106	CbGbCtD
Formoterol—CYP2D6—Ipratropium bromide—asthma	0.00124	0.00971	CbGbCtD
Formoterol—CYP2C9—Zafirlukast—asthma	0.00119	0.00935	CbGbCtD
Formoterol—CYP2C9—Arformoterol—asthma	0.00115	0.00903	CbGbCtD
Formoterol—CYP2D6—Zafirlukast—asthma	0.00109	0.00855	CbGbCtD
Formoterol—CYP2D6—Arformoterol—asthma	0.00105	0.00825	CbGbCtD
Formoterol—CYP2C19—Loratadine—asthma	0.00105	0.00823	CbGbCtD
Formoterol—CYP2D6—Tiotropium—asthma	0.000937	0.00736	CbGbCtD
Formoterol—CYP2C9—Theophylline—asthma	0.00092	0.00722	CbGbCtD
Formoterol—CYP2A6—Dexamethasone—asthma	0.000877	0.00688	CbGbCtD
Formoterol—CYP2C9—Montelukast—asthma	0.000872	0.00684	CbGbCtD
Formoterol—CYP2C9—Loratadine—asthma	0.000872	0.00684	CbGbCtD
Formoterol—CYP2D6—Theophylline—asthma	0.000841	0.0066	CbGbCtD
Formoterol—CYP2D6—Loratadine—asthma	0.000797	0.00626	CbGbCtD
Formoterol—CYP2C19—Prednisone—asthma	0.000581	0.00456	CbGbCtD
Formoterol—CYP2C19—Dexamethasone—asthma	0.000363	0.00285	CbGbCtD
Formoterol—CYP2C9—Dexamethasone—asthma	0.000302	0.00237	CbGbCtD
Formoterol—CYP2D6—Dexamethasone—asthma	0.000276	0.00216	CbGbCtD
Formoterol—Fenoterol—ADRB2—asthma	8.92e-05	0.171	CrCbGaD
Formoterol—Ritodrine—ADRB2—asthma	8.92e-05	0.171	CrCbGaD
Formoterol—Arbutamine—ADRB2—asthma	8.34e-05	0.16	CrCbGaD
Formoterol—Arformoterol—ADRB2—asthma	8.1e-05	0.155	CrCbGaD
Formoterol—Dobutamine—ADRB2—asthma	7.68e-05	0.147	CrCbGaD
Formoterol—Labetalol—ADRB2—asthma	5.92e-05	0.113	CrCbGaD
Formoterol—Isoprenaline—ADRB2—asthma	4.36e-05	0.0834	CrCbGaD
Formoterol—Rash—Montelukast—asthma	5.26e-06	0.000131	CcSEcCtD
Formoterol—Dermatitis—Montelukast—asthma	5.25e-06	0.000131	CcSEcCtD
Formoterol—Ill-defined disorder—Prednisolone—asthma	5.24e-06	0.00013	CcSEcCtD
Formoterol—Headache—Montelukast—asthma	5.22e-06	0.00013	CcSEcCtD
Formoterol—Visual impairment—Betamethasone—asthma	5.22e-06	0.00013	CcSEcCtD
Formoterol—Visual impairment—Dexamethasone—asthma	5.22e-06	0.00013	CcSEcCtD
Formoterol—Mental disorder—Methylprednisolone—asthma	5.22e-06	0.00013	CcSEcCtD
Formoterol—Malnutrition—Methylprednisolone—asthma	5.18e-06	0.000129	CcSEcCtD
Formoterol—Acute coronary syndrome—Prednisone—asthma	5.18e-06	0.000129	CcSEcCtD
Formoterol—Angioedema—Prednisolone—asthma	5.16e-06	0.000128	CcSEcCtD
Formoterol—Myocardial infarction—Prednisone—asthma	5.15e-06	0.000128	CcSEcCtD
Formoterol—Dizziness—Budesonide—asthma	5.15e-06	0.000128	CcSEcCtD
Formoterol—Ill-defined disorder—Hydrocortisone—asthma	5.12e-06	0.000127	CcSEcCtD
Formoterol—Vomiting—Salbutamol—asthma	5.11e-06	0.000127	CcSEcCtD
Formoterol—Malaise—Prednisolone—asthma	5.1e-06	0.000127	CcSEcCtD
Formoterol—Dysgeusia—Triamcinolone—asthma	5.09e-06	0.000126	CcSEcCtD
Formoterol—Rash—Salbutamol—asthma	5.07e-06	0.000126	CcSEcCtD
Formoterol—Dermatitis—Salbutamol—asthma	5.06e-06	0.000126	CcSEcCtD
Formoterol—Nausea—Arformoterol—asthma	5.06e-06	0.000126	CcSEcCtD
Formoterol—Angioedema—Hydrocortisone—asthma	5.04e-06	0.000125	CcSEcCtD
Formoterol—Headache—Salbutamol—asthma	5.04e-06	0.000125	CcSEcCtD
Formoterol—Back pain—Triamcinolone—asthma	5.03e-06	0.000125	CcSEcCtD
Formoterol—Malaise—Hydrocortisone—asthma	4.98e-06	0.000124	CcSEcCtD
Formoterol—Nausea—Montelukast—asthma	4.95e-06	0.000123	CcSEcCtD
Formoterol—Vomiting—Budesonide—asthma	4.95e-06	0.000123	CcSEcCtD
Formoterol—Rash—Budesonide—asthma	4.91e-06	0.000122	CcSEcCtD
Formoterol—Dermatitis—Budesonide—asthma	4.91e-06	0.000122	CcSEcCtD
Formoterol—Headache—Budesonide—asthma	4.88e-06	0.000121	CcSEcCtD
Formoterol—Hypertension—Prednisolone—asthma	4.88e-06	0.000121	CcSEcCtD
Formoterol—Arrhythmia—Dexamethasone—asthma	4.84e-06	0.00012	CcSEcCtD
Formoterol—Arrhythmia—Betamethasone—asthma	4.84e-06	0.00012	CcSEcCtD
Formoterol—Ill-defined disorder—Triamcinolone—asthma	4.82e-06	0.00012	CcSEcCtD
Formoterol—Ill-defined disorder—Methylprednisolone—asthma	4.81e-06	0.000119	CcSEcCtD
Formoterol—Nausea—Salbutamol—asthma	4.78e-06	0.000119	CcSEcCtD
Formoterol—Hypertension—Hydrocortisone—asthma	4.76e-06	0.000118	CcSEcCtD
Formoterol—Discomfort—Prednisolone—asthma	4.75e-06	0.000118	CcSEcCtD
Formoterol—Angioedema—Triamcinolone—asthma	4.75e-06	0.000118	CcSEcCtD
Formoterol—Angioedema—Methylprednisolone—asthma	4.74e-06	0.000118	CcSEcCtD
Formoterol—Myalgia—Hydrocortisone—asthma	4.7e-06	0.000117	CcSEcCtD
Formoterol—Malaise—Triamcinolone—asthma	4.69e-06	0.000116	CcSEcCtD
Formoterol—Anxiety—Hydrocortisone—asthma	4.68e-06	0.000116	CcSEcCtD
Formoterol—Malaise—Methylprednisolone—asthma	4.68e-06	0.000116	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.67e-06	0.000116	CcSEcCtD
Formoterol—Discomfort—Hydrocortisone—asthma	4.64e-06	0.000115	CcSEcCtD
Formoterol—Connective tissue disorder—Prednisone—asthma	4.63e-06	0.000115	CcSEcCtD
Formoterol—Nausea—Budesonide—asthma	4.63e-06	0.000115	CcSEcCtD
Formoterol—Anaphylactic shock—Prednisolone—asthma	4.61e-06	0.000115	CcSEcCtD
Formoterol—Oedema—Prednisolone—asthma	4.61e-06	0.000115	CcSEcCtD
Formoterol—Cough—Triamcinolone—asthma	4.53e-06	0.000113	CcSEcCtD
Formoterol—Anaphylactic shock—Hydrocortisone—asthma	4.5e-06	0.000112	CcSEcCtD
Formoterol—Oedema—Hydrocortisone—asthma	4.5e-06	0.000112	CcSEcCtD
Formoterol—Tachycardia—Prednisolone—asthma	4.5e-06	0.000112	CcSEcCtD
Formoterol—Hypertension—Triamcinolone—asthma	4.49e-06	0.000111	CcSEcCtD
Formoterol—Hypertension—Methylprednisolone—asthma	4.48e-06	0.000111	CcSEcCtD
Formoterol—Infection—Hydrocortisone—asthma	4.47e-06	0.000111	CcSEcCtD
Formoterol—Myalgia—Triamcinolone—asthma	4.42e-06	0.00011	CcSEcCtD
Formoterol—Nervous system disorder—Hydrocortisone—asthma	4.42e-06	0.00011	CcSEcCtD
Formoterol—Arthralgia—Methylprednisolone—asthma	4.41e-06	0.00011	CcSEcCtD
Formoterol—Myalgia—Methylprednisolone—asthma	4.41e-06	0.00011	CcSEcCtD
Formoterol—Anxiety—Methylprednisolone—asthma	4.4e-06	0.000109	CcSEcCtD
Formoterol—Tachycardia—Hydrocortisone—asthma	4.4e-06	0.000109	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.38e-06	0.000109	CcSEcCtD
Formoterol—Skin disorder—Hydrocortisone—asthma	4.37e-06	0.000109	CcSEcCtD
Formoterol—Ill-defined disorder—Betamethasone—asthma	4.37e-06	0.000109	CcSEcCtD
Formoterol—Ill-defined disorder—Dexamethasone—asthma	4.37e-06	0.000109	CcSEcCtD
Formoterol—Discomfort—Triamcinolone—asthma	4.37e-06	0.000109	CcSEcCtD
Formoterol—Discomfort—Methylprednisolone—asthma	4.36e-06	0.000108	CcSEcCtD
Formoterol—Dry mouth—Triamcinolone—asthma	4.33e-06	0.000107	CcSEcCtD
Formoterol—Angioedema—Dexamethasone—asthma	4.31e-06	0.000107	CcSEcCtD
Formoterol—Angioedema—Betamethasone—asthma	4.31e-06	0.000107	CcSEcCtD
Formoterol—Immune system disorder—Prednisone—asthma	4.26e-06	0.000106	CcSEcCtD
Formoterol—Malaise—Dexamethasone—asthma	4.25e-06	0.000106	CcSEcCtD
Formoterol—Malaise—Betamethasone—asthma	4.25e-06	0.000106	CcSEcCtD
Formoterol—Anaphylactic shock—Triamcinolone—asthma	4.24e-06	0.000105	CcSEcCtD
Formoterol—Oedema—Triamcinolone—asthma	4.24e-06	0.000105	CcSEcCtD
Formoterol—Anaphylactic shock—Methylprednisolone—asthma	4.23e-06	0.000105	CcSEcCtD
Formoterol—Arrhythmia—Prednisone—asthma	4.21e-06	0.000105	CcSEcCtD
Formoterol—Infection—Triamcinolone—asthma	4.21e-06	0.000105	CcSEcCtD
Formoterol—Hypotension—Hydrocortisone—asthma	4.21e-06	0.000105	CcSEcCtD
Formoterol—Infection—Methylprednisolone—asthma	4.2e-06	0.000104	CcSEcCtD
Formoterol—Insomnia—Prednisolone—asthma	4.17e-06	0.000104	CcSEcCtD
Formoterol—Nervous system disorder—Methylprednisolone—asthma	4.15e-06	0.000103	CcSEcCtD
Formoterol—Tachycardia—Triamcinolone—asthma	4.14e-06	0.000103	CcSEcCtD
Formoterol—Mental disorder—Prednisone—asthma	4.13e-06	0.000103	CcSEcCtD
Formoterol—Tachycardia—Methylprednisolone—asthma	4.13e-06	0.000103	CcSEcCtD
Formoterol—Skin disorder—Methylprednisolone—asthma	4.11e-06	0.000102	CcSEcCtD
Formoterol—Malnutrition—Prednisone—asthma	4.11e-06	0.000102	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Hydrocortisone—asthma	4.1e-06	0.000102	CcSEcCtD
Formoterol—Insomnia—Hydrocortisone—asthma	4.07e-06	0.000101	CcSEcCtD
Formoterol—Hypertension—Betamethasone—asthma	4.07e-06	0.000101	CcSEcCtD
Formoterol—Hypertension—Dexamethasone—asthma	4.07e-06	0.000101	CcSEcCtD
Formoterol—Myalgia—Dexamethasone—asthma	4.01e-06	9.97e-05	CcSEcCtD
Formoterol—Myalgia—Betamethasone—asthma	4.01e-06	9.97e-05	CcSEcCtD
Formoterol—Anxiety—Betamethasone—asthma	4e-06	9.94e-05	CcSEcCtD
Formoterol—Anxiety—Dexamethasone—asthma	4e-06	9.94e-05	CcSEcCtD
Formoterol—Discomfort—Dexamethasone—asthma	3.97e-06	9.85e-05	CcSEcCtD
Formoterol—Discomfort—Betamethasone—asthma	3.97e-06	9.85e-05	CcSEcCtD
Formoterol—Dyspepsia—Hydrocortisone—asthma	3.96e-06	9.85e-05	CcSEcCtD
Formoterol—Hypotension—Methylprednisolone—asthma	3.95e-06	9.82e-05	CcSEcCtD
Formoterol—Pain—Prednisolone—asthma	3.94e-06	9.8e-05	CcSEcCtD
Formoterol—Gastrointestinal disorder—Hydrocortisone—asthma	3.89e-06	9.66e-05	CcSEcCtD
Formoterol—Fatigue—Hydrocortisone—asthma	3.88e-06	9.65e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Triamcinolone—asthma	3.86e-06	9.6e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methylprednisolone—asthma	3.85e-06	9.58e-05	CcSEcCtD
Formoterol—Pain—Hydrocortisone—asthma	3.85e-06	9.57e-05	CcSEcCtD
Formoterol—Oedema—Betamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Formoterol—Anaphylactic shock—Betamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Formoterol—Oedema—Dexamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Formoterol—Anaphylactic shock—Dexamethasone—asthma	3.85e-06	9.56e-05	CcSEcCtD
Formoterol—Insomnia—Triamcinolone—asthma	3.84e-06	9.53e-05	CcSEcCtD
Formoterol—Insomnia—Methylprednisolone—asthma	3.83e-06	9.51e-05	CcSEcCtD
Formoterol—Infection—Betamethasone—asthma	3.82e-06	9.5e-05	CcSEcCtD
Formoterol—Infection—Dexamethasone—asthma	3.82e-06	9.5e-05	CcSEcCtD
Formoterol—Ill-defined disorder—Prednisone—asthma	3.81e-06	9.46e-05	CcSEcCtD
Formoterol—Feeling abnormal—Prednisolone—asthma	3.8e-06	9.44e-05	CcSEcCtD
Formoterol—Dyspnoea—Triamcinolone—asthma	3.78e-06	9.39e-05	CcSEcCtD
Formoterol—Nervous system disorder—Dexamethasone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Formoterol—Nervous system disorder—Betamethasone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Formoterol—Agitation—Prednisone—asthma	3.77e-06	9.37e-05	CcSEcCtD
Formoterol—Tachycardia—Betamethasone—asthma	3.76e-06	9.33e-05	CcSEcCtD
Formoterol—Tachycardia—Dexamethasone—asthma	3.76e-06	9.33e-05	CcSEcCtD
Formoterol—Angioedema—Prednisone—asthma	3.75e-06	9.32e-05	CcSEcCtD
Formoterol—Dyspepsia—Triamcinolone—asthma	3.73e-06	9.27e-05	CcSEcCtD
Formoterol—Dyspepsia—Methylprednisolone—asthma	3.72e-06	9.25e-05	CcSEcCtD
Formoterol—Feeling abnormal—Hydrocortisone—asthma	3.71e-06	9.22e-05	CcSEcCtD
Formoterol—Malaise—Prednisone—asthma	3.7e-06	9.2e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Hydrocortisone—asthma	3.68e-06	9.15e-05	CcSEcCtD
Formoterol—Urticaria—Prednisolone—asthma	3.66e-06	9.1e-05	CcSEcCtD
Formoterol—Fatigue—Triamcinolone—asthma	3.66e-06	9.08e-05	CcSEcCtD
Formoterol—Fatigue—Methylprednisolone—asthma	3.65e-06	9.06e-05	CcSEcCtD
Formoterol—Pain—Triamcinolone—asthma	3.63e-06	9.01e-05	CcSEcCtD
Formoterol—Hypotension—Dexamethasone—asthma	3.6e-06	8.93e-05	CcSEcCtD
Formoterol—Hypotension—Betamethasone—asthma	3.6e-06	8.93e-05	CcSEcCtD
Formoterol—Urticaria—Hydrocortisone—asthma	3.58e-06	8.89e-05	CcSEcCtD
Formoterol—Body temperature increased—Hydrocortisone—asthma	3.56e-06	8.84e-05	CcSEcCtD
Formoterol—Abdominal pain—Hydrocortisone—asthma	3.56e-06	8.84e-05	CcSEcCtD
Formoterol—Hypertension—Prednisone—asthma	3.54e-06	8.81e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Betamethasone—asthma	3.51e-06	8.71e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Dexamethasone—asthma	3.51e-06	8.71e-05	CcSEcCtD
Formoterol—Arthralgia—Prednisone—asthma	3.5e-06	8.68e-05	CcSEcCtD
Formoterol—Myalgia—Prednisone—asthma	3.5e-06	8.68e-05	CcSEcCtD
Formoterol—Feeling abnormal—Triamcinolone—asthma	3.49e-06	8.68e-05	CcSEcCtD
Formoterol—Feeling abnormal—Methylprednisolone—asthma	3.49e-06	8.66e-05	CcSEcCtD
Formoterol—Anxiety—Prednisone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Formoterol—Insomnia—Dexamethasone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Formoterol—Insomnia—Betamethasone—asthma	3.48e-06	8.65e-05	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.47e-06	8.62e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Methylprednisolone—asthma	3.46e-06	8.59e-05	CcSEcCtD
Formoterol—Discomfort—Prednisone—asthma	3.45e-06	8.58e-05	CcSEcCtD
Formoterol—Hypersensitivity—Prednisolone—asthma	3.4e-06	8.44e-05	CcSEcCtD
Formoterol—Dyspepsia—Dexamethasone—asthma	3.39e-06	8.41e-05	CcSEcCtD
Formoterol—Dyspepsia—Betamethasone—asthma	3.39e-06	8.41e-05	CcSEcCtD
Formoterol—Urticaria—Triamcinolone—asthma	3.37e-06	8.37e-05	CcSEcCtD
Formoterol—Urticaria—Methylprednisolone—asthma	3.36e-06	8.35e-05	CcSEcCtD
Formoterol—Body temperature increased—Triamcinolone—asthma	3.35e-06	8.33e-05	CcSEcCtD
Formoterol—Anaphylactic shock—Prednisone—asthma	3.35e-06	8.32e-05	CcSEcCtD
Formoterol—Oedema—Prednisone—asthma	3.35e-06	8.32e-05	CcSEcCtD
Formoterol—Abdominal pain—Methylprednisolone—asthma	3.34e-06	8.31e-05	CcSEcCtD
Formoterol—Infection—Prednisone—asthma	3.33e-06	8.27e-05	CcSEcCtD
Formoterol—Gastrointestinal disorder—Dexamethasone—asthma	3.32e-06	8.25e-05	CcSEcCtD
Formoterol—Gastrointestinal disorder—Betamethasone—asthma	3.32e-06	8.25e-05	CcSEcCtD
Formoterol—Hypersensitivity—Hydrocortisone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Formoterol—Fatigue—Betamethasone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Formoterol—Fatigue—Dexamethasone—asthma	3.32e-06	8.24e-05	CcSEcCtD
Formoterol—Pain—Dexamethasone—asthma	3.29e-06	8.17e-05	CcSEcCtD
Formoterol—Pain—Betamethasone—asthma	3.29e-06	8.17e-05	CcSEcCtD
Formoterol—Nervous system disorder—Prednisone—asthma	3.29e-06	8.16e-05	CcSEcCtD
Formoterol—Tachycardia—Prednisone—asthma	3.27e-06	8.12e-05	CcSEcCtD
Formoterol—Skin disorder—Prednisone—asthma	3.25e-06	8.09e-05	CcSEcCtD
Formoterol—Asthenia—Hydrocortisone—asthma	3.23e-06	8.03e-05	CcSEcCtD
Formoterol—Pruritus—Hydrocortisone—asthma	3.19e-06	7.92e-05	CcSEcCtD
Formoterol—Feeling abnormal—Dexamethasone—asthma	3.17e-06	7.88e-05	CcSEcCtD
Formoterol—Feeling abnormal—Betamethasone—asthma	3.17e-06	7.88e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Betamethasone—asthma	3.15e-06	7.82e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Dexamethasone—asthma	3.15e-06	7.82e-05	CcSEcCtD
Formoterol—Hypersensitivity—Triamcinolone—asthma	3.12e-06	7.76e-05	CcSEcCtD
Formoterol—Hypersensitivity—Methylprednisolone—asthma	3.12e-06	7.74e-05	CcSEcCtD
Formoterol—Diarrhoea—Hydrocortisone—asthma	3.08e-06	7.65e-05	CcSEcCtD
Formoterol—Urticaria—Betamethasone—asthma	3.06e-06	7.59e-05	CcSEcCtD
Formoterol—Urticaria—Dexamethasone—asthma	3.06e-06	7.59e-05	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Prednisone—asthma	3.05e-06	7.58e-05	CcSEcCtD
Formoterol—Dizziness—Prednisolone—asthma	3.05e-06	7.58e-05	CcSEcCtD
Formoterol—Asthenia—Triamcinolone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Formoterol—Body temperature increased—Dexamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Formoterol—Abdominal pain—Betamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Formoterol—Body temperature increased—Betamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Formoterol—Abdominal pain—Dexamethasone—asthma	3.04e-06	7.56e-05	CcSEcCtD
Formoterol—Asthenia—Methylprednisolone—asthma	3.04e-06	7.54e-05	CcSEcCtD
Formoterol—Insomnia—Prednisone—asthma	3.03e-06	7.53e-05	CcSEcCtD
Formoterol—Pruritus—Triamcinolone—asthma	3e-06	7.45e-05	CcSEcCtD
Formoterol—Pruritus—Methylprednisolone—asthma	2.99e-06	7.44e-05	CcSEcCtD
Formoterol—Dizziness—Hydrocortisone—asthma	2.98e-06	7.4e-05	CcSEcCtD
Formoterol—Dyspepsia—Prednisone—asthma	2.95e-06	7.33e-05	CcSEcCtD
Formoterol—Rash—Prednisolone—asthma	2.91e-06	7.22e-05	CcSEcCtD
Formoterol—Dermatitis—Prednisolone—asthma	2.9e-06	7.22e-05	CcSEcCtD
Formoterol—Diarrhoea—Methylprednisolone—asthma	2.89e-06	7.19e-05	CcSEcCtD
Formoterol—Fatigue—Prednisone—asthma	2.89e-06	7.18e-05	CcSEcCtD
Formoterol—Headache—Prednisolone—asthma	2.89e-06	7.18e-05	CcSEcCtD
Formoterol—Constipation—Prednisone—asthma	2.87e-06	7.12e-05	CcSEcCtD
Formoterol—Vomiting—Hydrocortisone—asthma	2.86e-06	7.11e-05	CcSEcCtD
Formoterol—Rash—Hydrocortisone—asthma	2.84e-06	7.05e-05	CcSEcCtD
Formoterol—Dermatitis—Hydrocortisone—asthma	2.84e-06	7.05e-05	CcSEcCtD
Formoterol—Headache—Hydrocortisone—asthma	2.82e-06	7.01e-05	CcSEcCtD
Formoterol—Dizziness—Triamcinolone—asthma	2.8e-06	6.97e-05	CcSEcCtD
Formoterol—Dizziness—Methylprednisolone—asthma	2.8e-06	6.95e-05	CcSEcCtD
Formoterol—Feeling abnormal—Prednisone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Formoterol—Asthenia—Dexamethasone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Formoterol—Asthenia—Betamethasone—asthma	2.76e-06	6.86e-05	CcSEcCtD
Formoterol—Gastrointestinal pain—Prednisone—asthma	2.74e-06	6.81e-05	CcSEcCtD
Formoterol—Nausea—Prednisolone—asthma	2.74e-06	6.8e-05	CcSEcCtD
Formoterol—Pruritus—Betamethasone—asthma	2.72e-06	6.76e-05	CcSEcCtD
Formoterol—Pruritus—Dexamethasone—asthma	2.72e-06	6.76e-05	CcSEcCtD
Formoterol—Vomiting—Triamcinolone—asthma	2.7e-06	6.7e-05	CcSEcCtD
Formoterol—Vomiting—Methylprednisolone—asthma	2.69e-06	6.68e-05	CcSEcCtD
Formoterol—Nausea—Hydrocortisone—asthma	2.68e-06	6.65e-05	CcSEcCtD
Formoterol—Rash—Triamcinolone—asthma	2.67e-06	6.64e-05	CcSEcCtD
Formoterol—Dermatitis—Triamcinolone—asthma	2.67e-06	6.64e-05	CcSEcCtD
Formoterol—Rash—Methylprednisolone—asthma	2.67e-06	6.63e-05	CcSEcCtD
Formoterol—Dermatitis—Methylprednisolone—asthma	2.67e-06	6.62e-05	CcSEcCtD
Formoterol—Urticaria—Prednisone—asthma	2.66e-06	6.61e-05	CcSEcCtD
Formoterol—Headache—Triamcinolone—asthma	2.66e-06	6.6e-05	CcSEcCtD
Formoterol—Headache—Methylprednisolone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Formoterol—Abdominal pain—Prednisone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Formoterol—Body temperature increased—Prednisone—asthma	2.65e-06	6.58e-05	CcSEcCtD
Formoterol—Diarrhoea—Betamethasone—asthma	2.63e-06	6.54e-05	CcSEcCtD
Formoterol—Diarrhoea—Dexamethasone—asthma	2.63e-06	6.54e-05	CcSEcCtD
Formoterol—Dizziness—Betamethasone—asthma	2.54e-06	6.32e-05	CcSEcCtD
Formoterol—Dizziness—Dexamethasone—asthma	2.54e-06	6.32e-05	CcSEcCtD
Formoterol—Nausea—Triamcinolone—asthma	2.52e-06	6.26e-05	CcSEcCtD
Formoterol—Nausea—Methylprednisolone—asthma	2.51e-06	6.24e-05	CcSEcCtD
Formoterol—Hypersensitivity—Prednisone—asthma	2.47e-06	6.13e-05	CcSEcCtD
Formoterol—Vomiting—Dexamethasone—asthma	2.45e-06	6.08e-05	CcSEcCtD
Formoterol—Vomiting—Betamethasone—asthma	2.45e-06	6.08e-05	CcSEcCtD
Formoterol—Rash—Dexamethasone—asthma	2.43e-06	6.03e-05	CcSEcCtD
Formoterol—Rash—Betamethasone—asthma	2.43e-06	6.03e-05	CcSEcCtD
Formoterol—Dermatitis—Betamethasone—asthma	2.42e-06	6.02e-05	CcSEcCtD
Formoterol—Dermatitis—Dexamethasone—asthma	2.42e-06	6.02e-05	CcSEcCtD
Formoterol—Headache—Dexamethasone—asthma	2.41e-06	5.99e-05	CcSEcCtD
Formoterol—Headache—Betamethasone—asthma	2.41e-06	5.99e-05	CcSEcCtD
Formoterol—Asthenia—Prednisone—asthma	2.4e-06	5.97e-05	CcSEcCtD
Formoterol—Pruritus—Prednisone—asthma	2.37e-06	5.89e-05	CcSEcCtD
Formoterol—ADRB1—Signaling Pathways—C5—asthma	2.31e-06	0.000428	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TACR1—asthma	2.31e-06	0.000428	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—CXCL8—asthma	2.31e-06	0.000428	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CSF2—asthma	2.31e-06	0.000428	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CARM1—asthma	2.3e-06	0.000427	CbGpPWpGaD
Formoterol—Diarrhoea—Prednisone—asthma	2.29e-06	5.7e-05	CcSEcCtD
Formoterol—Nausea—Betamethasone—asthma	2.29e-06	5.68e-05	CcSEcCtD
Formoterol—Nausea—Dexamethasone—asthma	2.29e-06	5.68e-05	CcSEcCtD
Formoterol—ADRB2—Signaling by GPCR—ITPR1—asthma	2.27e-06	0.000421	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—DCN—asthma	2.27e-06	0.00042	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDE4B—asthma	2.26e-06	0.000419	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C5—asthma	2.26e-06	0.000419	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TACR1—asthma	2.26e-06	0.000419	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—CXCL8—asthma	2.26e-06	0.000418	CbGpPWpGaD
Formoterol—Dizziness—Prednisone—asthma	2.22e-06	5.5e-05	CcSEcCtD
Formoterol—CYP2D6—Metabolism—ARG1—asthma	2.21e-06	0.00041	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALDH2—asthma	2.21e-06	0.000409	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ARG1—asthma	2.2e-06	0.000407	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EDN1—asthma	2.19e-06	0.000406	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALDH7A1—asthma	2.18e-06	0.000404	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCL5—asthma	2.17e-06	0.000403	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PLA2G4A—asthma	2.17e-06	0.000401	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CCR5—asthma	2.16e-06	0.0004	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EDN1—asthma	2.14e-06	0.000397	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CSF2—asthma	2.14e-06	0.000397	CbGpPWpGaD
Formoterol—Vomiting—Prednisone—asthma	2.13e-06	5.29e-05	CcSEcCtD
Formoterol—ADRB2—Signaling by GPCR—CCL5—asthma	2.13e-06	0.000394	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—IL2RA—asthma	2.13e-06	0.000394	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PLA2G4A—asthma	2.12e-06	0.000393	CbGpPWpGaD
Formoterol—Rash—Prednisone—asthma	2.11e-06	5.25e-05	CcSEcCtD
Formoterol—ADRB1—Signaling Pathways—CCR3—asthma	2.11e-06	0.000391	CbGpPWpGaD
Formoterol—Dermatitis—Prednisone—asthma	2.11e-06	5.24e-05	CcSEcCtD
Formoterol—ADRB2—GPCR downstream signaling—CCR5—asthma	2.11e-06	0.000391	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—C3—asthma	2.11e-06	0.000391	CbGpPWpGaD
Formoterol—Headache—Prednisone—asthma	2.1e-06	5.21e-05	CcSEcCtD
Formoterol—CYP2A6—Metabolism—GSTT1—asthma	2.1e-06	0.000389	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CSF2—asthma	2.1e-06	0.000388	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ARG2—asthma	2.09e-06	0.000387	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—IL2RA—asthma	2.08e-06	0.000385	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR3—asthma	2.07e-06	0.000383	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—C3—asthma	2.06e-06	0.000382	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPY—asthma	2.06e-06	0.000381	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPY—asthma	2.01e-06	0.000373	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALDH7A1—asthma	2e-06	0.000371	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PPP2CA—asthma	2e-06	0.00037	CbGpPWpGaD
Formoterol—Nausea—Prednisone—asthma	1.99e-06	4.94e-05	CcSEcCtD
Formoterol—ADRB1—Signaling Pathways—AGTR2—asthma	1.99e-06	0.000368	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALDH7A1—asthma	1.99e-06	0.000368	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCR5—asthma	1.96e-06	0.000363	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PPP2CA—asthma	1.95e-06	0.000362	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGTR2—asthma	1.94e-06	0.00036	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL2RA—asthma	1.93e-06	0.000358	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ARG2—asthma	1.92e-06	0.000356	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCR5—asthma	1.92e-06	0.000355	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—C3—asthma	1.91e-06	0.000355	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ARG2—asthma	1.9e-06	0.000353	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDNRB—asthma	1.9e-06	0.000352	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL2RA—asthma	1.89e-06	0.00035	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPS—asthma	1.88e-06	0.000349	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TAC1—asthma	1.88e-06	0.000349	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—C3—asthma	1.87e-06	0.000347	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDNRB—asthma	1.86e-06	0.000345	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCR3—asthma	1.85e-06	0.000342	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPS—asthma	1.84e-06	0.000341	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TAC1—asthma	1.84e-06	0.000341	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.83e-06	0.000339	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCR3—asthma	1.81e-06	0.000335	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CYBA—asthma	1.79e-06	0.000331	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PARP1—asthma	1.75e-06	0.000324	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL5—asthma	1.75e-06	0.000324	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CYBA—asthma	1.75e-06	0.000324	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NQO1—asthma	1.74e-06	0.000323	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX5AP—asthma	1.73e-06	0.000321	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX15—asthma	1.73e-06	0.000321	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL5—asthma	1.71e-06	0.000317	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PARP1—asthma	1.71e-06	0.000317	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ADCY2—asthma	1.71e-06	0.000316	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BDKRB2—asthma	1.69e-06	0.000313	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—POMC—asthma	1.69e-06	0.000312	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.67e-06	0.000309	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BDKRB2—asthma	1.65e-06	0.000306	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CHAT—asthma	1.65e-06	0.000306	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—POMC—asthma	1.65e-06	0.000306	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADCY2—asthma	1.63e-06	0.000303	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL3—asthma	1.63e-06	0.000302	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADCY2—asthma	1.6e-06	0.000296	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL3—asthma	1.59e-06	0.000295	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX5AP—asthma	1.59e-06	0.000295	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX15—asthma	1.59e-06	0.000295	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX5AP—asthma	1.58e-06	0.000292	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX15—asthma	1.58e-06	0.000292	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KNG1—asthma	1.54e-06	0.000285	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—POMC—asthma	1.53e-06	0.000284	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGTR1—asthma	1.53e-06	0.000283	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CHAT—asthma	1.52e-06	0.000281	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CHAT—asthma	1.5e-06	0.000279	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KNG1—asthma	1.5e-06	0.000279	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCL2—asthma	1.5e-06	0.000278	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—POMC—asthma	1.5e-06	0.000278	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGTR1—asthma	1.49e-06	0.000277	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6R—asthma	1.49e-06	0.000277	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL10—asthma	1.49e-06	0.000277	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—RHOA—asthma	1.49e-06	0.000275	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX5—asthma	1.47e-06	0.000273	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCL2—asthma	1.47e-06	0.000272	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK1—asthma	1.46e-06	0.000271	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6R—asthma	1.46e-06	0.000271	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL10—asthma	1.46e-06	0.000271	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTP1—asthma	1.45e-06	0.00027	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—RHOA—asthma	1.45e-06	0.000269	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADRB2—asthma	1.45e-06	0.000268	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HMOX1—asthma	1.43e-06	0.000266	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK1—asthma	1.43e-06	0.000265	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ITPR1—asthma	1.43e-06	0.000265	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAT—asthma	1.42e-06	0.000262	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CARM1—asthma	1.4e-06	0.00026	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—DCN—asthma	1.38e-06	0.000256	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ITPR1—asthma	1.37e-06	0.000254	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX5—asthma	1.35e-06	0.000251	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—RHOA—asthma	1.35e-06	0.00025	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALDH2—asthma	1.35e-06	0.000249	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX5—asthma	1.34e-06	0.000249	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ITPR1—asthma	1.34e-06	0.000248	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PLA2G4A—asthma	1.34e-06	0.000248	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—asthma	1.34e-06	0.000248	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—RHOA—asthma	1.32e-06	0.000245	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CD86—asthma	1.3e-06	0.000242	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CXCL8—asthma	1.3e-06	0.000242	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDN1—asthma	1.29e-06	0.00024	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	1.29e-06	0.00024	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CARM1—asthma	1.29e-06	0.000239	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL5—asthma	1.28e-06	0.000238	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTT1—asthma	1.28e-06	0.000237	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLA2G4A—asthma	1.28e-06	0.000237	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CARM1—asthma	1.28e-06	0.000237	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CD86—asthma	1.28e-06	0.000237	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CXCL8—asthma	1.28e-06	0.000236	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DCN—asthma	1.27e-06	0.000236	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDN1—asthma	1.27e-06	0.000235	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CSF2—asthma	1.27e-06	0.000235	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DCN—asthma	1.26e-06	0.000234	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL5—asthma	1.26e-06	0.000233	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLA2G4A—asthma	1.25e-06	0.000232	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—IL2—asthma	1.25e-06	0.000231	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CSF2—asthma	1.24e-06	0.000229	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALDH2—asthma	1.24e-06	0.000229	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SMAD3—asthma	1.23e-06	0.000228	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPP2CA—asthma	1.23e-06	0.000228	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALDH2—asthma	1.23e-06	0.000227	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—IL2—asthma	1.22e-06	0.000226	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SMAD3—asthma	1.21e-06	0.000223	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CXCL8—asthma	1.18e-06	0.00022	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.18e-06	0.000219	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	1.18e-06	0.000219	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PPP2CA—asthma	1.18e-06	0.000218	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTT1—asthma	1.18e-06	0.000218	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTT1—asthma	1.17e-06	0.000216	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CXCL8—asthma	1.16e-06	0.000215	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR5—asthma	1.16e-06	0.000214	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PPP2CA—asthma	1.15e-06	0.000214	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL2RA—asthma	1.14e-06	0.000211	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR5—asthma	1.13e-06	0.00021	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL2—asthma	1.13e-06	0.00021	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—C3—asthma	1.13e-06	0.00021	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL2RA—asthma	1.12e-06	0.000207	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL2—asthma	1.11e-06	0.000205	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C3—asthma	1.11e-06	0.000205	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFB—asthma	1.1e-06	0.000204	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFB—asthma	1.08e-06	0.0002	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	1.08e-06	0.000199	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NQO1—asthma	1.06e-06	0.000197	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—asthma	1.05e-06	0.000195	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADCY2—asthma	1.04e-06	0.000193	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.03e-06	0.000191	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—asthma	1.03e-06	0.000191	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FN1—asthma	9.93e-07	0.000184	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NQO1—asthma	9.78e-07	0.000181	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FN1—asthma	9.71e-07	0.00018	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NQO1—asthma	9.7e-07	0.00018	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADCY2—asthma	9.57e-07	0.000177	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADCY2—asthma	9.49e-07	0.000176	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—POMC—asthma	9.45e-07	0.000175	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	9.41e-07	0.000174	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—POMC—asthma	9.05e-07	0.000168	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	9e-07	0.000167	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTP1—asthma	8.87e-07	0.000164	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—asthma	8.85e-07	0.000164	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—POMC—asthma	8.85e-07	0.000164	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6R—asthma	8.82e-07	0.000164	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—asthma	8.75e-07	0.000162	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ITPR1—asthma	8.73e-07	0.000162	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EGFR—asthma	8.66e-07	0.00016	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—asthma	8.66e-07	0.00016	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—asthma	8.63e-07	0.00016	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6R—asthma	8.63e-07	0.00016	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—asthma	8.62e-07	0.00016	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EGFR—asthma	8.47e-07	0.000157	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—asthma	8.26e-07	0.000153	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—asthma	8.24e-07	0.000153	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	8.21e-07	0.000152	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTP1—asthma	8.16e-07	0.000151	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLA2G4A—asthma	8.15e-07	0.000151	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—asthma	8.15e-07	0.000151	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTP1—asthma	8.09e-07	0.00015	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—asthma	8.08e-07	0.00015	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—asthma	8.05e-07	0.000149	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ITPR1—asthma	8.03e-07	0.000149	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—asthma	7.98e-07	0.000148	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RHOA—asthma	7.97e-07	0.000148	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ITPR1—asthma	7.96e-07	0.000147	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—asthma	7.94e-07	0.000147	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—asthma	7.89e-07	0.000146	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—asthma	7.87e-07	0.000146	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RHOA—asthma	7.8e-07	0.000144	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—asthma	7.72e-07	0.000143	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—asthma	7.54e-07	0.00014	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPP2CA—asthma	7.51e-07	0.000139	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLA2G4A—asthma	7.5e-07	0.000139	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—asthma	7.5e-07	0.000139	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—asthma	7.43e-07	0.000138	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLA2G4A—asthma	7.43e-07	0.000138	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL8—asthma	7e-07	0.00013	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPP2CA—asthma	6.9e-07	0.000128	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPP2CA—asthma	6.85e-07	0.000127	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL8—asthma	6.84e-07	0.000127	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL2—asthma	6.69e-07	0.000124	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—asthma	6.65e-07	0.000123	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTEN—asthma	6.57e-07	0.000122	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL2—asthma	6.54e-07	0.000121	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—asthma	6.51e-07	0.000121	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—asthma	6.33e-07	0.000117	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTEN—asthma	6.29e-07	0.000117	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—asthma	6.19e-07	0.000115	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTEN—asthma	6.15e-07	0.000114	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—POMC—asthma	5.76e-07	0.000107	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—asthma	5.68e-07	0.000105	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STAT3—asthma	5.63e-07	0.000104	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—asthma	5.56e-07	0.000103	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STAT3—asthma	5.5e-07	0.000102	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—POMC—asthma	5.3e-07	9.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—POMC—asthma	5.25e-07	9.74e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—asthma	5.25e-07	9.73e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—asthma	5.22e-07	9.67e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGFR—asthma	5.11e-07	9.48e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—asthma	5.1e-07	9.46e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—asthma	5.02e-07	9.31e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGFR—asthma	5e-07	9.27e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—asthma	4.83e-07	8.95e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—asthma	4.79e-07	8.88e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—asthma	4.62e-07	8.56e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—asthma	4.6e-07	8.52e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—asthma	4.58e-07	8.49e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—asthma	4.23e-07	7.83e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—asthma	4.19e-07	7.77e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTEN—asthma	4.01e-07	7.43e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—asthma	3.93e-07	7.28e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—asthma	3.84e-07	7.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTEN—asthma	3.69e-07	6.83e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTEN—asthma	3.65e-07	6.77e-05	CbGpPWpGaD
